doi: 10.1016/j.fbio.2023.102425 15
One in five (19%) firms over 200 workers covers GLP-1 agonists for weight loss with more coverage among larger firms One-in-five (19%) firms with 200 or more workers, including 43% of firms with 5,000 or more workers, cover GLP-1 drugs for weight loss in their largest health plan in 2025
When food intake is low for a while, the body has less to work with, and some muscle breakdown can happen
"GLP-1 users don't eat on a subscription schedule, so we don't sell on one," said Jason Nista, CEO of Clean Eatz Kitchen
Peptides may be a factor that allows one or more body systems to relatively speaking, beat the clock and enhance a persons health to the extent that they seem at a biologically younger age than they otherwise might be at whatever calendar age they are at any given time